Pyridostigmine bromide

Amneal Pharmaceuticals LLC🇺🇸 United States

FDA Page

Effective Date: May 13, 2026
Approval ID: 52d6f195-165a-400b-a13b-489e94bcf0b0
Products: 1 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PYRIDOSTIGMINE BROMIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PYRIDOSTIGMINE BROMIDE EXTENDED-RELEASE TABLETS. PYRIDOSTIGMINE BROMIDE extended-release tablets, for oral use Initial U.S. Approval: 1955

Quick Stats

Total Products1

Labelers1

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.